Seagen Net Income 2006-2021 | SGEN

Seagen annual/quarterly net income history and growth rate from 2006 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Seagen net income for the quarter ending June 30, 2021 was $-0.085B, a 299.13% increase year-over-year.
  • Seagen net income for the twelve months ending June 30, 2021 was $0.597B, a 333.6% decline year-over-year.
  • Seagen annual net income for 2020 was $0.614B, a 486.81% decline from 2019.
  • Seagen annual net income for 2019 was $-0.159B, a 28.76% decline from 2018.
  • Seagen annual net income for 2018 was $-0.223B, a 77.4% increase from 2017.
Seagen Annual Net Income
(Millions of US $)
2020 $614
2019 $-159
2018 $-223
2017 $-126
2016 $-140
2015 $-120
2014 $-76
2013 $-63
2012 $-54
2011 $-152
2010 $-66
2009 $-82
2008 $-86
2007 $-49
2006 $-36
2005 $-29
Seagen Quarterly Net Income
(Millions of US $)
2021-06-30 $-85
2021-03-31 $-121
2020-12-31 $167
2020-09-30 $636
2020-06-30 $-21
2020-03-31 $-168
2019-12-31 $26
2019-09-30 $-92
2019-06-30 $-79
2019-03-31 $-13
2018-12-31 $-120
2018-09-30 $-67
2018-06-30 $76
2018-03-31 $-112
2017-12-31 $-59
2017-09-30 $50
2017-06-30 $-56
2017-03-31 $-60
2016-12-31 $-55
2016-09-30 $-32
2016-06-30 $-33
2016-03-31 $-20
2015-12-31 $-25
2015-09-30 $-26
2015-06-30 $-48
2015-03-31 $-22
2014-12-31 $-27
2014-09-30 $-16
2014-06-30 $-18
2014-03-31 $-16
2013-12-31 $-16
2013-09-30 $-24
2013-06-30 $-7
2013-03-31 $-16
2012-12-31 $-11
2012-09-30 $-14
2012-06-30 $-17
2012-03-31 $-12
2011-12-31 $-27
2011-09-30 $-41
2011-06-30 $-52
2011-03-31 $-33
2010-12-31 $-35
2010-09-30 $-35
2010-06-30 $-8
2010-03-31 $11
2009-12-31 $-12
2009-09-30 $-20
2009-06-30 $-22
2009-03-31 $-27
2008-12-31 $-31
2008-09-30 $-22
2008-06-30 $-16
2008-03-31 $-17
2007-12-31 $-15
2007-09-30 $-15
2007-06-30 $-11
2007-03-31 $-9
2006-12-31 $-10
2006-09-30 $-9
2006-06-30 $-9
2006-03-31 $-9
2005-12-31 $-7
2005-09-30 $-6
2005-06-30 $-8
2005-03-31 $-8
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $31.425B $2.176B
Seagen Inc. is a biotechnology company. It discovers, develops and commercializes transformative cancer medicines. The company operates principally in California, Canada, Switzerland and the European Union. Seagen Inc., formerly known as Seattle Genetics Inc., is headquartered in the Seattle.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.683B 8.63
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00